97. Ulcerative colitis Clinical trials / Disease details
Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00718094 (ClinicalTrials.gov) | March 2008 | 16/7/2008 | Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis | A Phase IIa Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract (Polyphenon E®) and Provide Preliminary Evidence to Support Its Efficacy in Ulcerative Colitis | Mild to Moderately Active Ulcerative Colitis | Drug: Polyphenon E®;Drug: Placebo Oral Tablet | University of Louisville | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | 18 Years | 85 Years | All | 20 | Phase 2 | United States |